Search results
Results from the WOW.Com Content Network
If you had an actual time machine and bought in pre-pandemic on March 1, 2020, you’d have paid $29.95 per share and could have converted a $1,000 investment into $7,802.52 today. Pfizer
J&JPRD was created in 2001 through the merging of various research organizations including McNeil Pharmaceuticals, Janssen Research Foundation, Three Dimensional Pharmaceuticals, and the R. W. Johnson Pharmaceutical Research Institute.
For the fiscal year 2023, Johnson & Johnson reported earnings of $35.15 billion, with an annual revenue of $85.16 billion, an increase of 10.57% over the previous fiscal cycle. Johnson & Johnson's shares traded at over $160 per share, and its market capitalization was valued at over $386.7 billion in July 2024.
Cerenovus Nimbus [10] Cerebase DA Guide Sheath [11] Trufill n-BCA Liquid Embolic System [12] Orthopedics (DePuy Synthes) Velys Digital Surgery platform [13] Attune Cementless Fixed Bearing Knee [14] Actis Hip Stem [15] Inhance Shoulder System [16] Dynatape Suture [17] Trumatch Graft Cage [18] Symphony OCT System [19] Surgery Vicryl [20]
The S&P 500 climbed 0.6% to add to what’s set to be one of its best years of the millennium. It’s the 56th time the index has hit an all-time high this year after climbing in 11 of the last 12 ...
In the quarter, Johnson Controls managed to boost its sales by 7% year over year; they landed at $7.4 billion. Non-GAAP (adjusted) net income saw a much more dynamic rise, improving by 19% to $858 ...
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
In September 2016, pharmaceutical and medical device company Johnson & Johnson announced they were buying Abbott Medical Optics for $4.3 billion. [13] On February 27, 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson. [14] In 2017, JJV acquired TearScience. [15]